These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2543891)

  • 21. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
    Bauernfeind A; Emminger G; Hörl G; Ott S; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(5):403-6. PubMed ID: 3121519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates.
    Sikorski A; Shamsheyeva A; Gamage D; Oppermann N; Bhalodi AA; Humphries RM
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33148710
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotics against Pseudomonas.
    Gillett AP
    J Antimicrob Chemother; 1982 Feb; 9 Suppl B():41-8. PubMed ID: 6801008
    [No Abstract]   [Full Text] [Related]  

  • 24. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
    Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
    J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
    Jones RN; Beach ML; Pfaller MA
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):161-3. PubMed ID: 11750171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobramycin, a new aminoglycoside antibiotic: Experience in urinary tract infections.
    Landes RR; Melnick I; Hoffman A; Fehrenbaker L
    South Med J; 1975 Jan; 68(1):116-7. PubMed ID: 125452
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS; Huband MD; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro susceptibility of Pseudomonas aeruginosa from bacteremic and fibrocystic patients to four quinolones and five other antipseudomonal antibiotics.
    Lester A; Andreasen JJ
    Scand J Infect Dis; 1988; 20(5):525-9. PubMed ID: 3146807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter study of the sensitivity of Pseudomonas aeruginosa to antimicrobial agents.
    Wiedemann B; Machka K; Malottke R
    Eur J Clin Microbiol; 1985 Apr; 4(2):229-30. PubMed ID: 3924613
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.
    Beale AS; Masson ND
    J Antimicrob Chemother; 1994 Dec; 34(6):1072-4. PubMed ID: 7730224
    [No Abstract]   [Full Text] [Related]  

  • 31. Kasugamycin in pseudomonas infections of the urinary tract.
    Ichikawa T; Umezawa H
    J Urol; 1967 May; 97(5):917-25. PubMed ID: 4961002
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of using aminoglycoside antibiotics in septicemia and urinary tract infections in newborn infants].
    Sentsova TB; Bombardirova EP; Mamedkulieva DT; Bekmukhambetova ER
    Antibiot Khimioter; 1990 Oct; 35(10):50-2. PubMed ID: 2126174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic quinolone antibiotics in children: a review of the use and safety.
    Grady RW
    Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed.
    Llor C; Aspiroz C; Cano A; Barranco M
    Aten Primaria; 2012 Jul; 44(7):443-4. PubMed ID: 22265580
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics.
    Majtán V; Hybenová D
    Folia Microbiol (Praha); 1996; 41(1):61-4. PubMed ID: 9090826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa: Pathogenicity and antimicrobial resistance in urinary tract infection].
    Paz-Zarza VM; Mangwani-Mordani S; Martínez-Maldonado A; Álvarez-Hernández D; Solano-Gálvez SG; Vázquez-López R
    Rev Chilena Infectol; 2019 Apr; 36(2):180-189. PubMed ID: 31344154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.
    Smith CB; Wilfert JN; Dans PE; Kurrus TA; Finland M
    J Infect Dis; 1970 Sep; 122():Suppl:S14-28. PubMed ID: 4990023
    [No Abstract]   [Full Text] [Related]  

  • 40. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.